Contact
Please use this form to send email to PR contact of this press release:
U.S. FDA grants orphan drug designation to glepaglutide for the treatment of short bowel syndrome
TO:
Please use this form to send email to PR contact of this press release:
U.S. FDA grants orphan drug designation to glepaglutide for the treatment of short bowel syndrome
TO: